DNASE1L3 Mediates Hepatocellular Carcinoma Tumor Growth and Organoid Models via the Wnt/β-Catenin Signaling Pathway
Oncology Research · 2026
DOI: 10.32604/or.2025.071739 ↗Kurz gefasst
Fachartikel in der Zeitschrift Oncology Research, 2026. Verfasst von Shulong Zhang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Surgery, Shanghai Xuhui Central Hospital, Zhongshan-Xuhui Hospital, Fudan University, Shanghai, 200031, China. Hauptthemen laut MEDLINE: Liver Neoplasms, Carcinoma, Hepatocellular, Wnt Signaling Pathway. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Background
Hepatocellular carcinoma (HCC) is a highly lethal malignancy driven by both intrinsic oncogenic pathways and immune microenvironmental regulation. Emerging evidence suggests that DNASE1L3 may influence tumor biology and immune responses; however, its specific roles in HCC progression and macrophage-mediated regulation remain unclear. This study aimed to elucidate the biological functions of DNASE1L3 in HCC and to determine how it modulates tumor behavior and immune interactions.
Methods
Bioinformatics analyses of the GSE41804 and Cancer Genome Atlas-Liver Hepatocellular Carcinoma (TCGA-LIHC) datasets were used to identify hub genes. Functional assays assessed the impact of DNASE1L3 on HCC cell proliferation, migration, invasion, and cell cycle progression. The effects of DNASE1L3 on macrophage polarization and the Wnt/β-catenin signaling pathway were examined using a co-culture system. An HCC organoid model was established to further validate its regulatory function.
Results
Eight prognostic signature genes were identified, with deoxyribonuclease I-like 3 (DNase I-like 3) selected as the hub gene. DNASE1L3 overexpression suppressed HCC cell growth, inhibited migration and invasion, induced G1 arrest, and modulated epithelial-mesenchymal transition (EMT) markers. DNASE1L3 knockdown promoted M2-like macrophage polarization. Mechanistically, DNASE1L3 interacted with β-catenin to enhance its ubiquitination and degradation, thereby inhibiting Wnt/β-catenin signaling and reducing PD-L1 expression. DNASE1L3 overexpression similarly restricted organoid growth and suppressed pathway activity.
Conclusion
DNASE1L3 acts as a negative regulator of HCC progression by targeting the Wnt/β-catenin pathway and reducing PD-L1 expression, thereby influencing both tumor cell behavior and macrophage-mediated immune responses.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of General Surgery, Shanghai Xuhui Central Hospital, Zhongshan-Xuhui Hospital, Fudan University, Shanghai, 200031, China.
- Department of the Third Ward of Special Treatment, Shanghai Eastern Hepatobiliary Surgery Hospital, Shanghai, 200438, China.
- Endoscopy Center, Minhang Hospital, Fudan University, No. 170 Xinsong Road, Shanghai, 201199, China.
- Shanghai Key Laboratory of Molecular Imaging, Jiading District Central Hospital Affiliated Shanghai University of Medicine and Health Sciences, Shanghai, 201318, China.
Zitieren
APA
Zhang, S., Zhao, Y., Geng, L., Song, F., Feng, L., Jiang, J., Cai, Q., & Fan, F. (2026). DNASE1L3 Mediates Hepatocellular Carcinoma Tumor Growth and Organoid Models via the Wnt/β-Catenin Signaling Pathway. Oncology Research. https://doi.org/10.32604/or.2025.071739
Vancouver
Zhang S, Zhao Y, Geng L, Song F, Feng L, Jiang J, et al. DNASE1L3 Mediates Hepatocellular Carcinoma Tumor Growth and Organoid Models via the Wnt/β-Catenin Signaling Pathway. Oncology Research. 2026. doi:10.32604/or.2025.071739
BibTeX
@article{Zhang2026,
author = {Zhang, Shulong and Zhao, Yijun and Geng, Li and Song, Feihong and Feng, Li and Jiang, Jun and Cai, Qianqian and Fan, Fei},
title = {DNASE1L3 Mediates Hepatocellular Carcinoma Tumor Growth and Organoid Models via the Wnt/β-Catenin Signaling Pathway},
journal = {Oncology Research},
year = {2026},
doi = {10.32604/or.2025.071739}
}
EUVIMED